← Leaderboards
Richard Bax
Biosyn, Inc.
$99,517
Attributed
$99,517
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,848,126 · 3
By mechanism
U19$1,748,609 · 2
R43$99,517 · 1
Top collaborators
No co-investigators on record.
Most similar at Biosyn, Inc.
Same institution · by research overlap
- Joseph W Romano$95,125
- Roger Schnaare$546,214
- Timothy J McCormick$990,353
- Robert J Buckheit$0
Others in their field
Top investigators on “Cooperative Study”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,953,039
- Eric S Lander · Whitehead Institute For Biomedical Res$342,301,804
- David R. Weir · University Of Michigan At Ann Arbor$323,894,310
- Norman Wolmark · Nsabp Foundation, Inc.$217,977,635
- Gregory H Reaman · National Childhood Cancer Foundation$202,419,402
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$201,297,180
Research focus
Cooperative StudyDrug Design /Synthesis /ProductionTopical Drug ApplicationAntiaids AgentBacterial DiseaseBiomedical FacilityChlamydia TrachomatisClinical ResearchConjunctivitisData ManagementDrug Adverse EffectDrug Screening /EvaluationDrug ToleranceEye InfectionsHerpes Simplex Virus 1Human Immunodeficiency Virus 1Information DisseminationLaboratory RabbitNeisseria GonorrhoeaeVirus DiseasesAntibacterial AgentsAntiinfective AgentsAntiviral Agents